Alkanediyl bridged benzimidazolo monomethine cyanine dyes, processes for their preparation, and photographic emulsions and elements containing such dyes
申请人:EASTMAN KODAK COMPANY
(a New Jersey corporation)
公开号:EP0121326A2
公开(公告)日:1984-10-10
Alkanediyl bridged benzimidazolo monomethine cyanine dyes wherein at least one benzimidazolo nucleus is provided with an electron-withdrawing group are photographically useful e.g., useful as blue sensitizers in silver halide emulsions and photographic elements. A disclosed preparation of the dyes includes producing an electron-withdrawing group substituted bis(2-nitrophenyl)-2-R'-propanediamide, where R' is hydrogen or alkyl: converting the nitro groups to primary amine substituents; removing the elements of water to effect ring closure; and thereafter providing the -CR'- linked benzimidazole nuclei so formed with an N,N'-alkanediyl bridging group and quaternizing substituents. Dye synthesis is completed by reducing the -CR1-linking group to the corresponding methine.
Bisbenzimidazole Derivatives as Potential Antimicrobial Agents: Design, Synthesis, Biological Evaluation and Pharmacophore Analysis
作者:Ronak Haj Ersan、Kayhan Bolelli、Serpil Gonca、Aylin Dogen、Serdar Burmaoglu、Oztekin Algul
DOI:10.1007/s11094-021-02389-x
日期:2021.5
In an attempt to design and synthesize a potent class of antimicrobials, 1,2-phenylenediamine derivatives were reacted with various aliphatic and heteroaliphatic dicarboxylic acids to generate a small library of 26 head-to-head bisbenzimidazole compounds (16 – 42) using the polyphosphoric acid method. These compounds were screened for their antibacterial activity and their antifungal activity. Compound 25 showed maximum potency against both Gram-positive and Gram-negative bacterial strains with minimum inhibitory concentration (MIC) values in the range of 7.81 – 31.25 μg/mL. In particular, it showed the maximum MIC values of 7.81 μg/mL against Gram-negative bacteria, which was four-fold more active than the standard drug ampicillin (MIC = 32.25 μg/mL). Compound 19 was found to be the most active against S. aureus with a MIC value of < 3.90 μg/mL, whereas the remaining compounds showed only low-to-moderate activity. Furthermore, all compounds exhibited low activity against all fungal strains in comparison to the standard drug fluconazole. I addition, pharmacophore hypotheses were generated to analyze structure–activity relationships between the molecular structures and antimicrobial activities on E. coli. This pharmacophore model can be useful in order to design new antimicrobial drugs. It can be suggested that the substitution of a phenyl ring at the 5/6 and 5′/6′ positions in symmetric bisbenzimidazole derivatives produces compounds with promising antimicrobial activity.